Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$56.80 USD
-0.58 (-1.01%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $56.82 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Earnings News For CYTK
-
Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
-
Cytokinetics: Q1 Earnings Snapshot
-
Cytokinetics Reports First Quarter 2024 Financial Results
-
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Cytokinetics to Announce First Quarter Results on May 8, 2024
-
Cytokinetics: Q4 Earnings Snapshot
-
Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
-
Cytokinetics Reports Fourth Quarter 2023 Financial Results
-
Cytokinetics to Announce Fourth Quarter Results on February 27, 2024
-
Cytokinetics (CYTK) Reports Q3 Loss, Misses Revenue Estimates
-
Cytokinetics: Q3 Earnings Snapshot
-
Cytokinetics Reports Third Quarter 2023 Financial Results
-
Cytokinetics to Announce Third Quarter Results on November 2, 2023
-
Cytokinetics (CYTK) Reports Q2 Loss, Misses Revenue Estimates
-
Cytokinetics Reports Second Quarter 2023 Financial Results
-
Cytokinetics to Announce Second Quarter Results on August 3, 2023
-
Cytokinetics (CYTK) Reports Q1 Loss, Tops Revenue Estimates
-
Cytokinetics: Q1 Earnings Snapshot
-
Cytokinetics Reports First Quarter 2023 Financial Results
-
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Cytokinetics to Announce First Quarter Results on May 4, 2023
-
Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
-
Cytokinetics: Q4 Earnings Snapshot
-
Cytokinetics Reports Fourth Quarter 2022 Financial Results
-
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?